Advancing BioCrossroads’ 10-Year Strategy
INDIANAPOLIS (March 18, 2026)—BioCrossroads today released its 2025 Annual Report, highlighting another landmark year for Indiana’s life sciences ecosystem. The report highlights BioCrossroads’ efforts to support robust talent pipelines, unprecedented economic impact, and national recognition of Indiana’s leadership in life sciences.
Indiana remained number one in the nation for life sciences and pharmaceutical exports. The report also highlights continued growth and momentum across the state’s life sciences and healthcare sectors: $102 billion total economic contribution from Indiana’s life sciences industry; 70,000 Hoosiers employed in life sciences across 3,312 establishments; $177,000 average annual wage in life sciences; 386,100 healthcare workers across Indiana; 36 venture capital deals totaling approximately $190 million invested in Indiana life sciences companies in 2025.
“By crossing the $100 billion threshold of total economic contribution, Indiana’s life sciences sector has reached a remarkable milestone that reflects decades of collaboration among industry, academia, philanthropy, government, and investors,” said Vince Wong, President and CEO of BioCrossroads. “More importantly, it shows that Indiana’s model of connecting research, development, manufacturing, talent, and entrepreneurship is producing real results.”
The Annual Report outlines progress across BioCrossroads’ 10-year Strategic Roadmap for Advancing Indiana’s Life Sciences Industries launched in January 2024, detailing major progress in advancing innovation, manufacturing, workforce development, capital formation, and ecosystem collaboration that are strengthening Indiana’s position as a global life sciences leader.
Last year, BioCrossroads expanded support for startups and founders through the Startup Catalyst Center, including the launch of the AXIS Mentoring Program, which connected 14 founders with 36 mentors and delivered more than 50 hours of mentoring in its first year. The organization also helped support the launch of Indiana University Launch Accelerator for Biosciences (IU LAB) to accelerate the commercialization of university-based life sciences research.
Indiana strengthened its role as a global manufacturing hub, highlighted by securing its designation as the Radiopharmaceutical Capital of the World™, reflecting the state’s leadership in research, development, manufacturing, logistics, and specialized workforce capabilities for the rapidly growing radiopharmaceutical sector.
BioCrossroads continued to build talent pipelines through efforts such as the BioTrain initiative, part of the federally funded Heartland BioWorks Tech Hub powered by the Applied Research Institute (ARI) and supported by the federal Economic Development Administration (EDA). The program is developing new biomanufacturing training capacity in partnership with Ivy Tech Community College and Purdue University, leveraging the Midwest-region exclusive curriculum partnership with the National Institute of Bioprocessing Research and Training (NIBRT). BioCrossroads also was designated to serve as the Industry Talent Associations for Healthcare and Life Sciences sectors to help launch the Indiana Career Apprenticeship Pathway (INCAP) to build scalable pathways into high-demand healthcare and life sciences careers, starting with high-school work-based apprenticeships. In 2025, BioCrossroads also expanded statewide and national engagement through convenings, partnerships, and communications efforts designed to elevate Indiana’s life sciences thought leadership.
The 2025 BioCrossroads Life Sciences Summit, held in partnership with AgriNovus Indiana, brought together more than 350 leaders to explore Indiana’s emerging leadership in One Health, connecting human, animal, and plant health innovation. BioCrossroads hosted four FrameWORX events, bringing together more than 500 industry participants to discuss key issues including research commercialization, workforce development, and emerging technologies.
###
About BioCrossroads
An initiative of the CEOs of Indiana Corporate Partnership (CICP), BioCrossroads is a catalyst for Indiana’s life sciences sector, advancing the state’s position as a global leader in research, development, manufacturing, and healthcare innovation. Through strategic initiatives, industry partnerships, and ecosystem development, BioCrossroads supports the growth of life sciences companies, talent, and investment across Indiana. It supports the region’s existing enterprises and encourages new business development. The initiative fosters public-private collaboration by uniting a diverse range of academic, industry, and philanthropic stakeholders, all collectively focused on advancing Indiana’s life sciences sector. Committed to supporting the growth of capital investments and talent development, BioCrossroads provides support to both existing and new life sciences enterprises, including the Indiana Health Information Exchange, OrthoWorx, and the Indiana Biosciences Research Institute. BioCrossroads champions the advancement of cutting-edge research and development, plays a crucial role in building and nurturing a robust talent pipeline, and is dedicated to establishing Indiana as a thriving hub for life sciences manufacturing. To learn more about BioCrossroads, visit biocrossroads.com.
